Point-of-Care Diagnostics Market Insights and Projection to 2034

Creator: Zion Market Research
License: https://www.zionmarketresearch.com/privacy-policy

Market Size in 2025	Market Forecast in 2034	CAGR (in %)	Base Year
USD 42,180 Million	USD 98,640 Million	9.9%	2025

Table Of Content

Methodology

Research Methodology

The Global Point-of-Care Diagnostics Market report employs a robust three-stage research framework combining primary intelligence gathering, secondary data analysis, and multi-source data triangulation. The research design was specifically structured to capture both the supply-side dynamics of the POC diagnostics value chain — from reagent manufacturing and device engineering to distribution and regulatory approval — and the demand-side dynamics operating across healthcare procurement, reimbursement policy, and clinical adoption patterns.
Primary research was conducted through structured interviews and surveys with stakeholders across the POC diagnostics value chain. Stakeholder categories consulted include: hospital CIOs and procurement directors at major health systems in the U.S., Germany, and Japan; clinical laboratory directors and point-of-care coordinators at acute care facilities; medical affairs executives and commercial directors at POC diagnostic device manufacturers; managed care pharmacy directors and reimbursement policy analysts; and public health procurement officers at national health ministries in emerging markets including India, Brazil, and South Africa.
Secondary research encompassed a comprehensive review of publicly available information sources directly relevant to the POC diagnostics sector: U.S. FDA device clearance databases (510(k) and PMA records); EMA CE-IVD mark registrations; WHO Essential Diagnostics List and prequalification records; CLIA-waiver status databases; earnings call transcripts and annual reports from publicly listed POC diagnostics companies; peer-reviewed publications from journals including Lancet Infectious Diseases, NEJM, and Clinical Chemistry; trade press including Diagnostics World and The Dark Report; and government healthcare expenditure data from the OECD Health Statistics database and WHO Global Health Observatory.
Market sizing and forecast modelling was conducted using a bottom-up triangulation methodology: individual sub-segment revenue was built from volume estimates (units deployed, tests performed) and average selling price data, then aggregated to the regional and global level. Forecast projections use a compound growth model anchored to the 9.9% base-case CAGR, with scenario analysis prepared for conservative (regulatory headwinds, reimbursement tightening) and optimistic (accelerated CLIA-waived clearances, emerging market health ministry procurement) scenarios. All data was validated through back-testing against publicly disclosed revenue figures from key market participants and cross-checked against third-party data sources for consistency.

FrequentlyAsked Questions

What does the Zion Market Research's Point-of-Care Diagnostics report include?

The Zion Market Research's Global Point-of-Care Diagnostics Market report comprises 300+ pages covering: full market sizing and forecasting for 2019–2034 across five segmentation dimensions (product, technology, mode of purchase, end user, and region); 110 data tables and 80 figures; 15 company profiles with competitive strategy analysis; country-level forecasts for 35+ geographies across all six Zion Market Research regions; full DROC analysis (drivers, restraints, opportunities, challenges); research methodology documentation; and recent developments table covering 2024–2025 strategic events. The report is delivered in PDF format with immediate digital download.

What is the Point-of-Care Diagnostics market size and forecast?

According to Zion Market Research, the Global Point-of-Care Diagnostics market was valued at USD 42,180 Mn in 2025 and is projected to reach USD 98,640 Mn by 2034, expanding at a CAGR of 9.9% during the forecast period 2026–2034. Historical data covers 2019–2025. North America leads with approximately 42% revenue share; Asia Pacific is the fastest-growing region at approximately 10.7% CAGR. Infectious disease testing is the dominant product segment.

How is the Point-of-Care Diagnostics market segmented in this report?

The report segments the market across five dimensions: (1) By Product — glucose testing, infectious disease testing, cardiac markers, coagulation testing, HbA1c testing, pregnancy & fertility testing, drug-of-abuse testing, and others; (2) By Technology — lateral flow assays, molecular diagnostics, immunoassay analyzers, and biochemistry; (3) By Mode of Purchase — prescription-based and over-the-counter; (4) By End User — hospitals, clinics, home settings, diagnostic centres, and ambulatory care centres; (5) By Region — six ZMR regions covering 35+ countries.

Which countries are covered in this report?

The report provides country-level analysis across 35+ geographies. North America: The U.S., Canada, Mexico. Europe: Germany, France, U.K., Italy, Spain, Russia, BENELUX, Sweden, Denmark, Poland, Austria, Rest of Europe. Asia Pacific: China, Japan, India, South Korea, Australia, Thailand, Indonesia, Vietnam, Malaysia, Philippines, Taiwan, Rest of Asia Pacific. Latin America: Brazil, Argentina, Colombia, Chile, Peru, Rest of Latin America. The Middle East: GCC (Saudi Arabia, UAE, Qatar, Kuwait, Bahrain, Oman), Israel, Turkey, Iran, Rest of Middle East. Africa: South Africa, Egypt, Nigeria, Algeria, Morocco, Rest of Africa. The Middle East and Africa are always covered as separate regions — never combined.

What customization options are available?

Zion Market Research offers 10% free customization with every report purchase — allowing buyers to specify additional segments, specific country breakdowns, or adjusted forecast scenarios at no extra cost. Beyond 10%, paid customization is available including: extended forecast periods (post-2034); additional country-level deep-dives not included in the standard scope; competitor-specific analysis; and primary research add-ons including executive interviews with specific stakeholder types. Contact sales@zionmarketresearch.com or call +1 (302) 444-0166 to discuss your specific customisation requirements.

How can I access or purchase the Point-of-Care Diagnostics report?

Three options are available: (1) Free Sample: Access sample chapters, key data tables, and the condensed TOC (2) Full Report: Purchase the complete 300+ page PDF (3) Custom Research Inquiry: Contact the ZMR team directly at sales@zionmarketresearch.com | +1 (302) 444-0166 | Toll Free: +1 (855) 465-4651 to discuss multi-user licensing, enterprise access, or custom scope requirements.